z-logo
open-access-imgOpen Access
Use of liver stiffness measurements in acute decompensated heart failure: new applications of a non‐invasive technique
Author(s) -
Dhillon Jaspreet K.,
Fong Michael W.,
Fong TseLing
Publication year - 2022
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.14038
Subject(s) - medicine , acute decompensated heart failure , heart failure , cardiology , exacerbation , transient elastography , gold standard (test) , central venous pressure , intensive care medicine , liver biopsy , blood pressure , heart rate , biopsy
Heart failure (HF) is a complex disease associated with multisystem organ failure, recurrent hospital admissions, and increased mortality. Acute decompensated heart failure (ADHF) increases central venous pressure (CVP) with resultant hepatic congestion, and this relationship has prognostic significance. The gold standard method of measuring CVP, right heart catheterization, is invasive and costly, prompting further investigation into more accurate non‐invasive assessments in HF patients, including liver elastography. Liver elastography relies on imaging techniques to assess liver stiffness measurements (LSM), with high values equating to increased stiffness. While this was developed to assess fibrosis in liver disease, LSM also reflect increased CVP and hepatic congestion. Multiple studies involving ADHF patients, find that increased LSM are independently predictive of increased cardiac events, all‐cause mortality, and worse post‐operative outcome after both acute HF exacerbation and left ventricular assist device (LVAD) placement. In this review, we discuss the role of LSM as a surrogate for CVP and their applications in determining prognosis in both the ADHF and LVAD populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here